.collection-type-index .page-content { padding: 96px 20px; }

What People Are Saying

gradient.png


The sRNAlytics platform illuminates 'dark matter' in biological data, allowing the development of precise diagnostics and therapeutics


- Dr. Jun Axup Science Director, IndieBio

Grey.png


sRNAlytics’ platform has application across many areas of interest to AstraZeneca. We’re excited to watch their company mature in the [AstraZeneca] incubator and work with them.

- Head of Neurology, AstraZeneca

gradient.png


sRNAlytics is uncovering biomarkers that make it feasible to identify people who will develop neurological diseases, but do not yet show any symptoms

- Dr. Richard H. Myers Professor, Boston University

 

Our Partners

astrazeneca-logo-png-astrazeneca-logo-astra-zeneca-4902.png
Unknown-1.png
 
2linecntposRGB1000-01-24zmj08.png
 
5NarrowLogo_ex_768.png